EICHORCondition: Rectal Adenocarcinoma · Non Metastatic · Sponsor: Fondazione del Piemonte per l'Oncologia
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
A phase II, single-center, non-profit, interventional study on patients affected by rectal adenocarcinoma. Patients will be stratified into three groups based on pre-treatment clinical stage. The study investigates and may propose a comprehensive, stage-specific, multimodal approach to rectal adenocarcinoma, with a focus on organ preservation even in early stages (cT1-2N0). When organ-sparing strategies are not feasible, the approach prioritizes minimally invasive techniques (laparoscopic and robotic) to reduce the physical, psychological, and quality-of-life impact on patients.
This description comes directly from the study's public registry record.
Alfredo Mellano, MD · +390119933445 · alfredo.mellano@ircc.it
Annamaria Nuzzo, PHD · annamaria.nuzzo@ircc.it
Always discuss trial participation with your own doctor first.
| Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment | Candiolo, Turin, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06952101